(Q81709718)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Phase II trial of dolastatin-10 in patients with advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

main subject

phase II clinical trial

1 reference

7

Steven R Alberts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

Edith A Perez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

David W Hillman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Paul A Fishkin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

James E Krook

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Winston W Tan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Phillip A Kuriakose

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Shaker R Dakhil

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

257-261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868383%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-005-6735-y

11 January 2020

exact match

0 references

cites work

Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification

1 reference

12 December 2020

Cancer statistics, 2005

1 reference

12 December 2020

Effects of dolastatins on human B-lymphocytic leukemia cell lines

1 reference

12 December 2020

Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules

1 reference

12 December 2020

Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma

1 reference

12 December 2020

Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain

1 reference

12 December 2020

Effect of dolastatin 10 on human non-Hodgkin's lymphoma cell lines

1 reference

12 December 2020

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors

1 reference

12 December 2020

Dolastatin-10 in metastatic melanoma: a phase II and pharmokinetic trial of the California Cancer Consortium

1 reference

12 December 2020

Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer?

1 reference

12 December 2020

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B

1 reference

12 December 2020

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

12 December 2020

Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.

1 reference

12 December 2020

Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity

1 reference

12 December 2020

Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.

1 reference

12 December 2020